IP Library › Granted Patent US 8,822,405
Granted Patent B2
US 8,822,405 · App. 12/548,784 · Granted Sep 2, 2014

Uses of mammalian cytokines and agonists; related reagents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,822,405
App. No.
12/548,784
Granted
Sep 2, 2014
Kind
B2
Abstract

The present invention relates generally to uses of TSLP in the treatment of cancer.

Claims (7)

1. A method of treating a subject having an epithelial tumor comprising administering to the subject an effective amount of a TSLP protein, wherein the method does not comprise administering to the subject dendritic cells.

2. The method of claim 1 , wherein the epithelial tumor is a:

a) breast tumor;

b) colon tumor;

c) lung tumor;

d) ovary tumor; or

e) prostate tumor.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →